• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

槲皮素及其衍生物在新冠病毒防护和预防方面的治疗意义。

Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic.

作者信息

Ho Wan-Yi, Shen Zi-Han, Chen Yijing, Chen Ting-Hsu, Lu XiaoLin, Fu Yaw-Syan

机构信息

Department of Anatomy, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Clinical Medicine, Xiamen Medical College, Xiamen, 361023, Fujian, China.

出版信息

Heliyon. 2024 Apr 30;10(9):e30080. doi: 10.1016/j.heliyon.2024.e30080. eCollection 2024 May 15.

DOI:10.1016/j.heliyon.2024.e30080
PMID:38765079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11098804/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel human coronavirus, which has triggered a global pandemic of the coronavirus infectious disease 2019 (COVID-19). Outbreaks of emerging infectious diseases continue to challenge human health worldwide. The virus conquers human cells through the angiotensin-converting enzyme 2 receptor-driven pathway by mostly targeting the human respiratory tract. Quercetin is a natural flavonoid widely represented in the plant kingdom. Cumulative evidence has demonstrated that quercetin and its derivatives have various pharmacological properties including anti-cancer, anti-hypertension, anti-hyperlipidemia, anti-hyperglycemia, anti-microbial, antiviral, neuroprotective, and cardio-protective effects, because it is a potential treatment for severe inflammation and acute respiratory distress syndrome. Furthermore, it is the main life-threatening condition in patients with COVID-19. This article provides a comprehensive review of the primary literature on the predictable effectiveness of quercetin and its derivatives docked to multi-target of SARS-CoV-2 and host cells via and some of validation through , , and clinically to fight SARS-CoV-2 infections, contribute to the reduction of inflammation, which suggests the preventive and therapeutic latency of quercetin and its derived-products against COVID-19 pandemic, multisystem inflammatory syndromes (MIS), and long-COVID.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新型人类冠状病毒,它引发了2019冠状病毒病(COVID-19)的全球大流行。新发传染病的爆发继续在全球范围内挑战人类健康。该病毒主要通过靶向人类呼吸道,通过血管紧张素转换酶2受体驱动的途径攻克人类细胞。槲皮素是一种在植物界广泛存在的天然黄酮类化合物。越来越多的证据表明,槲皮素及其衍生物具有多种药理特性,包括抗癌、抗高血压、抗高血脂、抗高血糖、抗微生物、抗病毒、神经保护和心脏保护作用,因为它是治疗严重炎症和急性呼吸窘迫综合征的潜在药物。此外,它是COVID-19患者主要的危及生命的病症。本文全面综述了关于槲皮素及其衍生物通过与SARS-CoV-2和宿主细胞的多靶点对接的可预测有效性的主要文献,以及通过……、……和临床验证以对抗SARS-CoV-2感染、减轻炎症的一些内容,这表明槲皮素及其衍生产品对COVID-19大流行、多系统炎症综合征(MIS)和新冠后遗症具有预防和治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/d7bdc96ae52b/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/9d77b8745c35/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/72dfac4771ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/48c72f90f765/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/2e7588059e1f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/8d3a845035fc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/d7bdc96ae52b/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/9d77b8745c35/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/72dfac4771ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/48c72f90f765/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/2e7588059e1f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/8d3a845035fc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e79/11098804/d7bdc96ae52b/mmcfigs1.jpg

相似文献

1
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic.槲皮素及其衍生物在新冠病毒防护和预防方面的治疗意义。
Heliyon. 2024 Apr 30;10(9):e30080. doi: 10.1016/j.heliyon.2024.e30080. eCollection 2024 May 15.
2
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19.槲皮素及其衍生物的抗病毒、免疫调节和抗凝作用:在COVID-19预防和管理中的潜在作用。
J Pharm Anal. 2022 Feb;12(1):29-34. doi: 10.1016/j.jpha.2021.09.009. Epub 2021 Sep 20.
4
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
5
Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.天然化合物对 SARS 刺突糖蛋白-人血管紧张素转换酶 2 和 SARS-CoV-2 主蛋白酶的分子对接和 ADMET 预测。
Arch Razi Inst. 2021 Sep 1;76(3):453-459. doi: 10.22092/ari.2020.351202.1517. eCollection 2021 Summer.
6
The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19.BEN815作为一种抗炎、抗病毒和抗氧化剂用于治疗新型冠状病毒肺炎的潜力。
Phytomed Plus. 2021 Nov;1(4):100058. doi: 10.1016/j.phyplu.2021.100058. Epub 2021 Mar 18.
7
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
8
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.抗新冠病毒候选药物:天然产物在新型冠状病毒感染管理中的潜在生物学活性综述
J Tradit Complement Med. 2021 Mar;11(2):144-157. doi: 10.1016/j.jtcme.2020.12.001. Epub 2020 Dec 29.
9
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
10
Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review.载有槲皮素纳米粒的工程细胞外囊泡作为抗 SARS-CoV-2 感染的抗病毒治疗的保护作用:前瞻性综述。
Front Immunol. 2022 Dec 8;13:1040027. doi: 10.3389/fimmu.2022.1040027. eCollection 2022.

引用本文的文献

1
Unveiling Pharmacological Mechanisms of (Abresham), a Traditional Arabic Unani Medicine for Ischemic Heart Disease: An Integrative Molecular Simulation Study.揭示(阿卜勒沙姆)治疗缺血性心脏病的传统阿拉伯尤纳尼医学的药理机制:一项综合分子模拟研究
Pharmaceutics. 2025 Feb 24;17(3):295. doi: 10.3390/pharmaceutics17030295.
2
Integrated study of Quercetin as a potent SARS-CoV-2 RdRp inhibitor: Binding interactions, MD simulations, and In vitro assays.槲皮素作为一种有效的新型冠状病毒核糖核酸聚合酶抑制剂的综合研究:结合相互作用、分子动力学模拟和体外试验。
PLoS One. 2024 Dec 3;19(12):e0312866. doi: 10.1371/journal.pone.0312866. eCollection 2024.
3

本文引用的文献

1
Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients.老年患者中SARS-CoV-2初次感染和再次感染的比较结果。
Front Public Health. 2024 Feb 16;12:1337646. doi: 10.3389/fpubh.2024.1337646. eCollection 2024.
2
Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023.2022 年 12 月至 2023 年 1 月,中国主要 BA.5 奥密克戎亚变体再感染和严重程度的风险。
Emerg Microbes Infect. 2024 Dec;13(1):2292071. doi: 10.1080/22221751.2023.2292071. Epub 2024 Feb 6.
3
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review.
-Derived Supplementation Improves the Severity of COVID-19 Symptoms among Elderly Nursing Home Residents.
维生素D衍生补充剂可改善老年疗养院居民新冠病毒疾病19症状的严重程度
Foods. 2024 Aug 27;13(17):2718. doi: 10.3390/foods13172718.
4
Antiviral Properties of Leaf Extracts against Respiratory Viruses.叶提取物的抗病毒特性对呼吸道病毒。
Viruses. 2024 Jul 25;16(8):1199. doi: 10.3390/v16081199.
新冠病毒大流行后毛霉病的毒力特征和新型药物输送策略:全面综述。
Front Immunol. 2023 Sep 25;14:1264502. doi: 10.3389/fimmu.2023.1264502. eCollection 2023.
4
Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms.通过先进的药物递送平台应对全球猴痘(Mpox)疫情的再度爆发。
Travel Med Infect Dis. 2023 Nov-Dec;56:102636. doi: 10.1016/j.tmaid.2023.102636. Epub 2023 Aug 24.
5
NASAFYTOL supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial.新冠病毒感染住院成人补充NASAFYTOL:一项探索性开放标签随机对照试验的结果。
Front Nutr. 2023 Jun 22;10:1137407. doi: 10.3389/fnut.2023.1137407. eCollection 2023.
6
The possible therapeutic role of curcumin and quercetin in the of COVID-19-Results from a pragmatic randomized clinical trial.姜黄素和槲皮素在COVID-19治疗中的潜在作用——一项实用随机临床试验的结果
Front Nutr. 2023 Jan 18;9:1023997. doi: 10.3389/fnut.2022.1023997. eCollection 2022.
7
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial.槲皮素作为早期新冠病毒肺炎的一种可能的辅助药物:一项随机临床试验的最终结果
Front Pharmacol. 2023 Jan 13;13:1096853. doi: 10.3389/fphar.2022.1096853. eCollection 2022.
8
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.姜黄素、槲皮素和维生素D3联合口服作为COVID-19轻至中度症状辅助治疗的初步开放标签随机对照试验结果
Front Pharmacol. 2022 Jun 7;13:898062. doi: 10.3389/fphar.2022.898062. eCollection 2022.
9
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD.多酚、类黄酮和炎性小体:香烟烟雾在 COPD 中的作用。
Eur Respir Rev. 2022 Jun 14;31(164). doi: 10.1183/16000617.0028-2022. Print 2022 Jun 30.
10
MIS-A after COVID-19: Points to Ponder.新冠病毒感染后儿童多系统炎症综合征:思考要点
Indian J Crit Care Med. 2022 Summer;26(4):531. doi: 10.5005/jp-journals-10071-24180.